THOUSAND OAKS, Calif.,June 12, 2024/PRNewswire/ --Amgen(NASDAQ:AMGN) today announced the presentation of data across its diverse portfolio and pipeline at theEuropean Alliance of Associations for Rheumatology's(EULAR) 2024Congress,June 12-15inVienna. The 27 abstracts fromAmgen-sponsored a...
Pipeline Problems Mar Amgen’s Q4 Beat Amgen outperformed expectations in the fourth quarter of 2024, but revealed an FDA hold on early-stage obesity asset AMG 513 and the discontinuation of other programs. February 5, 2025· 3 min read· Tristan Manalac Load More JOBS...
The drug, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific antibodies designed to attach to a cancer cell and an immune cell, bringing them together so that the body's immune system can kill the cancer. Results from a mid-stage trial published last year in t...
THOUSAND OAKS, Calif.,Sept. 13, 2024/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of new data across its broad oncology pipeline and portfolio at theEuropean Society for Medical Oncology (ESMO) Congress2024, taking placeSept. 13-17inBarcelona. The abs...
Additional Analyses Support Eculizumab (a biosimilar candidate to SOLIRIS®) as a Potential Option in Paroxysmal Nocturnal Hemoglobinuria THOUSAND OAKS, Calif.,Dec. 8, 2023/PRNewswire/ --Amgen(NASDAQ:AMGN) today announced the presentation of new data from its blood cancer portfolio and pi...
For the last four decades, we have been dedicated to discovering the firsts that matter in oncology and to finding ways to reduce the burden of cancer. Building on our heritage, Amgen continues to advance the largest pipeline in the Company's histo...
Adis is an information provider.We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. ...
Pipeline Amgen Science Podcasts Scientific Advisory Boards Biosimilars Clinical Trials About Clinical Trials Amgen Clinical Trials Clinical Trial Diversity and Representation Information for Healthcare Professionals Clinical Trial Transparency, Data Sharing and Disclosure Practices Clinical Out-of-Ho...
juncture in its evolution,” said Dr. Kaplan. “I look forward to working with the team to strengthen key areas of the business, positioning the Company for sustained success. Our commitment to advancing the organization will give us the potential to develop a pipeline of transformative therapies...
Create a free Seeking Alpha account to access breaking news and valuable research tools »Create Free AccountSeeking Alpha - Power to Investors Power to Investors Follow us Download app Account Account Login Manage My Portfolio Privacy Create Portfolio Portfolio Health Check Alert Preferences ...